Rev­o­lu­tion Med­i­cines looks to raise $230M in new pub­lic of­fer­ing

Af­ter its IPO al­most two and a half years ago, a Cal­i­for­nia biotech is gath­er­ing up more fi­nanc­ing.

Tar­get­ed on­col­o­gy biotech Rev­o­lu­tion Med­i­cines put out …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER